HCW Biologics Files Prospectus For Resale Of Up To 1,807,228 Shares Underlying Armistice Capital Warrants
https://www.sec.gov/Archives/edgar/data/1828673/000149315226045532/forms-1.htm
Stocks · News reference
HCW Biologics Says IND Filing For Solid Tumor Drug HCW11-018b On Track For 1H 2027 After FDA Meeting
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HCW Biologics shares are trading higher after the company announced pricing of $1.5 million private placement.
8-K filing — HCW Biologics Inc. (HCWB)
Filed: 2026-09-24 AccNo: 0001493152-26-044078 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits